Cardio-Oncology: Cancer Treatment and Your Heart

Clinical Trial Finder

This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions

Condition:   Breast Cancer
Interventions:   Device: SmartGoggle;   Other: Cardio-Green;   Device: SPY Elite;   Device: gamma probe;   Other: Blue Dyes
Sponsor:   Case Comprehensive Cancer Center
Recruiting

Molecular Genetics Studies of Cancer Patients and Their Relatives

Condition:   Malignant Neoplasm
Interventions:   Other: Biospecimen Collection;   Other: Questionnaire Administration
Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
Recruiting

Liraglutide Effects on Epicardial Fat Inflammatory Genes

Conditions:   Type2 Diabetes;   Coronary Artery Disease
Interventions:   Drug: Liraglutide Pen Injector [Victoza];   Drug: matching liraglutide-placebo pre-filled pens
Sponsor:   University of Miami
Recruiting

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Condition:   Non-Small-Cell Lung
Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Placebo Comparator;   Drug: Nab-paclitaxel;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine
Sponsor:   Hoffmann-La Roche
Recruiting

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Condition:   Carcinoma, Non-Small-Cell Lung
Interventions:   Drug: Alectnib;   Drug: Cisplatin;   Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Pemetrexed;   Drug: Carboplatin
Sponsor:   Hoffmann-La Roche
Recruiting

A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Condition:   Cancer
Intervention:   Drug: Atezolizumab
Sponsor:   Hoffmann-La Roche
Recruiting

A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Condition:   Carcinoma, Non-Small-Cell Lung
Intervention:   Drug: Atezolizumab
Sponsor:   Hoffmann-La Roche
Active, not recruiting

A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Condition:   Small Cell Lung Carcinoma
Interventions:   Drug: Atezolizumab;   Drug: Carboplatin;   Drug: Etoposide
Sponsor:   Hoffmann-La Roche
Recruiting